Navigating the landscape of core outcome set development in dermatology

Cecilia A. C. Prinsen, Phyllis I. Spuls, Jan Kottner, Kim S. Thomas, Christian Apfelbacher, Joanne R. Chalmers, Stefanie Deckert, Masutaka Furue, Louise Gerbens, Jamie Kirkham, Eric L. Simpson, Murad Alam, Katrin Balzer, Dimitri Beeckman, Viktoria Eleftheriadou, Khaled Ezzedine, Sophie E. R. Horbach, John R. Ingram, Alison M. Layton, Karsten Weller & 4 others Thomas Wild, Albert Wolkerstorfer, Hywel C. Williams, Jochen Schmitt

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific condition) in dermatology is increasing in pace. A total of 44 dermatology-related COS projects have been registered in the online Core Outcome Measures in Effectiveness Trials database (http://www.comet-initiative.org/studies/search) and include studies on 26 different skin diseases. With the increasing number of COSs in dermatology, care is needed to ensure the delivery of high-quality COSs that meet quality standards when using state-of-the-art methods. In 2015, the Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) was established. CS-COUSIN is an international, multidisciplinary working group aiming to improve the development and implementation of COSs in dermatology. CS-COUSIN has developed guidance on how to develop high-quality COSs for skin diseases and supports dermatology-specific COS initiatives. Currently, 17 COS development groups are affiliated with CS-COUSIN and following standardized COS development processes. To ensure successful uptake of COSs in dermatology, researchers, clinicians, systematic reviewers, guideline developers, and other stakeholders should use existing COSs in their work.
Original languageEnglish
Pages (from-to)297-305
JournalJournal of the American Academy of Dermatology
Volume81
Issue number1
DOIs
Publication statusPublished - 2019

Cite this

Prinsen, C. A. C., Spuls, P. I., Kottner, J., Thomas, K. S., Apfelbacher, C., Chalmers, J. R., ... Schmitt, J. (2019). Navigating the landscape of core outcome set development in dermatology. Journal of the American Academy of Dermatology, 81(1), 297-305. https://doi.org/10.1016/j.jaad.2019.03.009
Prinsen, Cecilia A. C. ; Spuls, Phyllis I. ; Kottner, Jan ; Thomas, Kim S. ; Apfelbacher, Christian ; Chalmers, Joanne R. ; Deckert, Stefanie ; Furue, Masutaka ; Gerbens, Louise ; Kirkham, Jamie ; Simpson, Eric L. ; Alam, Murad ; Balzer, Katrin ; Beeckman, Dimitri ; Eleftheriadou, Viktoria ; Ezzedine, Khaled ; Horbach, Sophie E. R. ; Ingram, John R. ; Layton, Alison M. ; Weller, Karsten ; Wild, Thomas ; Wolkerstorfer, Albert ; Williams, Hywel C. ; Schmitt, Jochen. / Navigating the landscape of core outcome set development in dermatology. In: Journal of the American Academy of Dermatology. 2019 ; Vol. 81, No. 1. pp. 297-305.
@article{252a190a190a4465956ee31a5771db03,
title = "Navigating the landscape of core outcome set development in dermatology",
abstract = "The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific condition) in dermatology is increasing in pace. A total of 44 dermatology-related COS projects have been registered in the online Core Outcome Measures in Effectiveness Trials database (http://www.comet-initiative.org/studies/search) and include studies on 26 different skin diseases. With the increasing number of COSs in dermatology, care is needed to ensure the delivery of high-quality COSs that meet quality standards when using state-of-the-art methods. In 2015, the Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) was established. CS-COUSIN is an international, multidisciplinary working group aiming to improve the development and implementation of COSs in dermatology. CS-COUSIN has developed guidance on how to develop high-quality COSs for skin diseases and supports dermatology-specific COS initiatives. Currently, 17 COS development groups are affiliated with CS-COUSIN and following standardized COS development processes. To ensure successful uptake of COSs in dermatology, researchers, clinicians, systematic reviewers, guideline developers, and other stakeholders should use existing COSs in their work.",
keywords = "CS-COUSIN, Cochrane Skin, clinical trials, core outcome set, dermatology, development, implementation",
author = "Prinsen, {Cecilia A. C.} and Spuls, {Phyllis I.} and Jan Kottner and Thomas, {Kim S.} and Christian Apfelbacher and Chalmers, {Joanne R.} and Stefanie Deckert and Masutaka Furue and Louise Gerbens and Jamie Kirkham and Simpson, {Eric L.} and Murad Alam and Katrin Balzer and Dimitri Beeckman and Viktoria Eleftheriadou and Khaled Ezzedine and Horbach, {Sophie E. R.} and Ingram, {John R.} and Layton, {Alison M.} and Karsten Weller and Thomas Wild and Albert Wolkerstorfer and Williams, {Hywel C.} and Jochen Schmitt",
year = "2019",
doi = "10.1016/j.jaad.2019.03.009",
language = "English",
volume = "81",
pages = "297--305",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",

}

Prinsen, CAC, Spuls, PI, Kottner, J, Thomas, KS, Apfelbacher, C, Chalmers, JR, Deckert, S, Furue, M, Gerbens, L, Kirkham, J, Simpson, EL, Alam, M, Balzer, K, Beeckman, D, Eleftheriadou, V, Ezzedine, K, Horbach, SER, Ingram, JR, Layton, AM, Weller, K, Wild, T, Wolkerstorfer, A, Williams, HC & Schmitt, J 2019, 'Navigating the landscape of core outcome set development in dermatology' Journal of the American Academy of Dermatology, vol. 81, no. 1, pp. 297-305. https://doi.org/10.1016/j.jaad.2019.03.009

Navigating the landscape of core outcome set development in dermatology. / Prinsen, Cecilia A. C.; Spuls, Phyllis I.; Kottner, Jan; Thomas, Kim S.; Apfelbacher, Christian; Chalmers, Joanne R.; Deckert, Stefanie; Furue, Masutaka; Gerbens, Louise; Kirkham, Jamie; Simpson, Eric L.; Alam, Murad; Balzer, Katrin; Beeckman, Dimitri; Eleftheriadou, Viktoria; Ezzedine, Khaled; Horbach, Sophie E. R.; Ingram, John R.; Layton, Alison M.; Weller, Karsten; Wild, Thomas; Wolkerstorfer, Albert; Williams, Hywel C.; Schmitt, Jochen.

In: Journal of the American Academy of Dermatology, Vol. 81, No. 1, 2019, p. 297-305.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Navigating the landscape of core outcome set development in dermatology

AU - Prinsen, Cecilia A. C.

AU - Spuls, Phyllis I.

AU - Kottner, Jan

AU - Thomas, Kim S.

AU - Apfelbacher, Christian

AU - Chalmers, Joanne R.

AU - Deckert, Stefanie

AU - Furue, Masutaka

AU - Gerbens, Louise

AU - Kirkham, Jamie

AU - Simpson, Eric L.

AU - Alam, Murad

AU - Balzer, Katrin

AU - Beeckman, Dimitri

AU - Eleftheriadou, Viktoria

AU - Ezzedine, Khaled

AU - Horbach, Sophie E. R.

AU - Ingram, John R.

AU - Layton, Alison M.

AU - Weller, Karsten

AU - Wild, Thomas

AU - Wolkerstorfer, Albert

AU - Williams, Hywel C.

AU - Schmitt, Jochen

PY - 2019

Y1 - 2019

N2 - The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific condition) in dermatology is increasing in pace. A total of 44 dermatology-related COS projects have been registered in the online Core Outcome Measures in Effectiveness Trials database (http://www.comet-initiative.org/studies/search) and include studies on 26 different skin diseases. With the increasing number of COSs in dermatology, care is needed to ensure the delivery of high-quality COSs that meet quality standards when using state-of-the-art methods. In 2015, the Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) was established. CS-COUSIN is an international, multidisciplinary working group aiming to improve the development and implementation of COSs in dermatology. CS-COUSIN has developed guidance on how to develop high-quality COSs for skin diseases and supports dermatology-specific COS initiatives. Currently, 17 COS development groups are affiliated with CS-COUSIN and following standardized COS development processes. To ensure successful uptake of COSs in dermatology, researchers, clinicians, systematic reviewers, guideline developers, and other stakeholders should use existing COSs in their work.

AB - The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific condition) in dermatology is increasing in pace. A total of 44 dermatology-related COS projects have been registered in the online Core Outcome Measures in Effectiveness Trials database (http://www.comet-initiative.org/studies/search) and include studies on 26 different skin diseases. With the increasing number of COSs in dermatology, care is needed to ensure the delivery of high-quality COSs that meet quality standards when using state-of-the-art methods. In 2015, the Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) was established. CS-COUSIN is an international, multidisciplinary working group aiming to improve the development and implementation of COSs in dermatology. CS-COUSIN has developed guidance on how to develop high-quality COSs for skin diseases and supports dermatology-specific COS initiatives. Currently, 17 COS development groups are affiliated with CS-COUSIN and following standardized COS development processes. To ensure successful uptake of COSs in dermatology, researchers, clinicians, systematic reviewers, guideline developers, and other stakeholders should use existing COSs in their work.

KW - CS-COUSIN

KW - Cochrane Skin

KW - clinical trials

KW - core outcome set

KW - dermatology

KW - development

KW - implementation

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067479598&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30878565

U2 - 10.1016/j.jaad.2019.03.009

DO - 10.1016/j.jaad.2019.03.009

M3 - Article

VL - 81

SP - 297

EP - 305

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 1

ER -